The Trump administration will announce a potential link between acetaminophen use during pregnancy and autism risk, despite lacking conclusive scientific evidence. They will also promote leucovorin, a vitamin B form, as a possible autism treatment, although research supporting its efficacy is limited. This announcement contradicts existing scientific consensus and previous court findings. The administration's actions are seen by many as politically motivated, undermining established science regarding autism causes and treatments. Experts highlight the importance of genetics in autism and caution against unsubstantiated claims.

Prepared by Olivia Bennett and reviewed by editorial team.